Trademark: 85085419
Status Date
Friday, April 27, 2018
Registration Number
4027807
Registration Date
Tuesday, September 20, 2011
Filing Date
Thursday, July 15, 2010
Published for Opposition
Tuesday, July 5, 2011
Cancellation Date
Friday, April 27, 2018
1 Active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; Adjuvants for use in manufacture of vaccines; Protein arrays and nucleotide arrays for scientific and medical laboratory use; Nucleic acids, proteins and peptides for laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory use
5 Pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Vaccines; Adjuvants for medical purposes except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Chemical reagents used for medical or veterinary purposes; Biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; Macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes
42 Medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Providing medical and scientific research information, consultancy, and advisory services, all in the fields of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Compiling data for medical and scientific research, clinical trials, and drug admission
44 Medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; Veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes
Apr 27, 2018
Cancelled Sec. 8 (6-Yr)
Sep 20, 2016
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jan 22, 2015
Teas Change Of Correspondence Received
Mar 25, 2014
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 25, 2014
Teas Change Of Owner Address Received
Nov 12, 2013
Teas Change Of Correspondence Received
Sep 20, 2011
Registered-Principal Register
Jul 5, 2011
Official Gazette Publication Confirmation E-Mailed
Jul 5, 2011
Published For Opposition
May 31, 2011
Law Office Publication Review Completed
May 26, 2011
Approved For Pub - Principal Register
May 26, 2011
Previous Allowance Count Withdrawn
May 11, 2011
Approved For Pub - Principal Register
May 11, 2011
Teas/Email Correspondence Entered
May 11, 2011
Correspondence Received In Law Office
Apr 28, 2011
Assigned To Lie
Apr 22, 2011
Teas Response To Office Action Received
Oct 29, 2010
Notification Of Priority Action E-Mailed
Oct 29, 2010
Priority Action E-Mailed
Oct 29, 2010
Priority Action Written
Oct 28, 2010
Assigned To Examiner
Aug 13, 2010
Teas Amendment Entered Before Attorney Assigned
Aug 13, 2010
Teas Voluntary Amendment Received
Jul 21, 2010
New Application Office Supplied Data Entered In Tram
Jul 19, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
